Skip to main content
Premium Trial:

Request an Annual Quote

Artemis DNA to Provide Datar Cancer Genetics Liquid Biopsy Tests in the US, Vietnam Under $250M Deal

NEW YORK – Datar Cancer Genetics said on Monday that it has struck a $250 million contract with US diagnostic laboratory company Artemis DNA, which will provide Datar's cancer detection liquid biopsies in the US and Vietnam.

The five-year exclusive agreement covers two Datar cancer screening and diagnostic tests: Trucheck Pragma, a noninvasive, blood-based screening test for lung, stomach, colon, pancreas, prostate, breast, and ovarian cancers; and Cancertrack, which evaluates therapy response, resistance, and cancer recurrence in patients. The assays will be initially offered as laboratory-developed tests in the US, according to Datar.

In addition, Artemis DNA will provide Datar with CLIA-certified, CAP-accredited testing facilities in Texas and California to enable the commercial launch of various cancer screening and diagnostic tests developed by Datar.

"We are extremely delighted to offer our highly accurate cancer detection technology for the benefit of patients in the USA and Vietnam in partnership with Artemis DNA," Datar Cancer Genetics Chairman Rajan Datar said in a statement. "We will continue to expand our offerings in the USA and European markets with high standards of accuracy and quality of service."

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.